Teriflunomide modulates the PD-1/PD-L1 axis and enhances antitumor immunity in colorectal cancer
18 March 2026 at 08:00
Oncogenesis, Published online: 18 March 2026; doi:10.1038/s41389-026-00607-3
Teriflunomide modulates the PD-1/PD-L1 axis and enhances antitumor immunity in colorectal cancer